Ergomed names Lewis Cameron as next COO
Ergomed
1,346.00p
08:02 13/11/23
Pharmaceutical industry services provider Ergomed named Lewis Cameron as its next chief operating officer on Monday.
FTSE AIM All-Share
745.29
16:54 18/04/24
Pharmaceuticals & Biotechnology
21,132.77
17:14 18/04/24
Cameron, an experienced senior executive in the global pharmaceutical services sector, will take over as COO and join the group's board on 20 January 2020.
Ergomed's new COO will join the AIM-listed firm from US group LabCorp - where he has acted as the company's head of global clinical development at its Covance subsidiary since 2017.
Chairman Dr Miroslav Reljanović said: "We are delighted to further strengthen our management team with Lewis's appointment.
"He will take on operational responsibility across our whole business and I have no doubt we will benefit from his considerable operational expertise, M&A experience and proven track record of growth across the pharmaceutical services sector as we deliver on our strategy."
As of 1330 GMT, Ergomed shares were down 0.04% at 377.85p.